GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Interest Coverage

Genomma Lab InternacionalB de CV (MEX:LABB) Interest Coverage : 4.71 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Genomma Lab InternacionalB de CV's Operating Income for the three months ended in Jun. 2024 was MXN983 Mil. Genomma Lab InternacionalB de CV's Interest Expense for the three months ended in Jun. 2024 was MXN-209 Mil. Genomma Lab InternacionalB de CV's interest coverage for the quarter that ended in Jun. 2024 was 4.71. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's Interest Coverage or its related term are showing as below:

MEX:LABB' s Interest Coverage Range Over the Past 10 Years
Min: 0.58   Med: 5.17   Max: 6.76
Current: 4.09


MEX:LABB's Interest Coverage is ranked worse than
72.59% of 664 companies
in the Drug Manufacturers industry
Industry Median: 12.21 vs MEX:LABB: 4.09

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Genomma Lab InternacionalB de CV Interest Coverage Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Genomma Lab InternacionalB de CV Interest Coverage Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.75 6.36 6.74 6.28 3.92

Genomma Lab InternacionalB de CV Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.93 4.26 3.17 4.26 4.71

Competitive Comparison of Genomma Lab InternacionalB de CV's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Interest Coverage falls into.



Genomma Lab InternacionalB de CV Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Genomma Lab InternacionalB de CV's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Genomma Lab InternacionalB de CV's Interest Expense was MXN-830 Mil. Its Operating Income was MXN3,252 Mil. And its Long-Term Debt & Capital Lease Obligation was MXN4,234 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*3252.178/-829.903
=3.92

Genomma Lab InternacionalB de CV's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Here, for the three months ended in Jun. 2024, Genomma Lab InternacionalB de CV's Interest Expense was MXN-209 Mil. Its Operating Income was MXN983 Mil. And its Long-Term Debt & Capital Lease Obligation was MXN4,846 Mil.

Interest Coverage=-1* Operating Income (Q: Jun. 2024 )/Interest Expense (Q: Jun. 2024 )
=-1*983.284/-208.556
=4.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Genomma Lab InternacionalB de CV  (MEX:LABB) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Genomma Lab InternacionalB de CV Interest Coverage Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines